Modulation of mammalian life span by the short isoform of p53

Genes and Development

Volumn 18, Issue 3, 2004, Pages 306-319

  Maier, Bernhard ^a   Gluba, Wendy ^a   Bernier, Brian ^a   Turner, Terry ^a   Mohammad, Khalid ^a   Guise, Theresa ^a   Sutherland, Ann ^a   Thorner, Michael ^a   Scrable, Heidi ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Aging; Akt; Daf2; GH; Growth retardation; Sir2; Testis

Indexed keywords

ISOPROTEIN; PROTEIN KINASE; PROTEIN P21; PROTEIN P44; PROTEIN P53; SOMATOMEDIN;

AGING; ANIMAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE; CANCER INHIBITION; CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE CONTROL; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GENETICS; GROWTH; GROWTH RETARDATION; LONGEVITY; MALE; METABOLISM; MOUSE; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TISSUE REGENERATION; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

AGING; ANIMALS; BONE AND BONES; CELL DIVISION; CELL SURVIVAL; GENES, P53; GROWTH; LONGEVITY; MICE; MICE, TRANSGENIC; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; SOMATOMEDINS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MAMMALIA; MUS MUSCULUS;

EID: 1042266548     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.1162404     Document Type: Article

References (46)

1. Beausejour, C.M., Krtolica, A., Galimi, F., Narita, M., Lowe, S.W., Yaswen, P., and Campisi, J. 2003. Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO J. 22: 4212-4222.
2. Bellido, T., Jilka, R.L., Boyce, B.F., Girasole, G., Broxmeyer, H., Dalrymple, S.A., Murray, R., and Manolagas, S.C. 1995. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J. Clin. Invest. 95: 2886-2895.
3. Bluher, M., Kahn, B.B., and Kahn, C.R. 2003. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299: 572-574.
4. Bulavin, D.V., Saito, S., Hollander, M.C., Sakaguchi, K., Anderson, C.W., Appella, E., and Fornace Jr, A.J. 1999. Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J. 18: 6845-6854.
5. Clancy, D.J., Gems, D., Harshman, L.G., Oldham, S., Stocker, H., Hafen, E., Leevers, S.J., and Partridge, L. 2001. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292: 104-106.
6. Courtois, S., Verhaegh, G., North, S., Luciani, M.G., Lassus, P., Hibner, U., Oren, M., and Hainaut, P. 2002. DeltaN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53. Oncogene 21: 6722-6728.
7. Cronin, C.A., Gluba, W., and Scrable, H. 2001. The lac operator-repressor system is functional in the mouse. Genes & Dev. 15: 1506-1517.
8. Derry, W.B., Putzke, A.P., and Rothman, J.H. 2001. Caenorhabditis elegans p53: Role in apoptosis, meiosis, and stress resistance. Science 294: 591-595.
9. Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., Pereira-Smith, O., et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. 92: 9363-9367.
10. Erben, R.G., Eberle, J., Stahr, K., and Goldberg, M. 2000. Androgen deficiency induces high turnover osteopenia in aged male rats: A sequential histomorphometric study. J. Bone Miner. Res. 15: 1085-1098.
11. Flurkey, K., Papaconstantinou, J., Miller, R.A., and Harrison, D.E. 2001. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl. Acad. Sci. 98: 6736-6741.
12. Frye, R.A. 1999. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. Biochem. Biophys. Res. Commun. 260: 273-279.
13. Garcia-Cao, I., Garcia-Cao, M., Martin-Caballero, J., Criado, L.M., Klatt, P., Flores, J.M., Weill, J.C., Blasco, M.A., and Serrano, M. 2002. 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 21: 6225-6235.
14. Gu, M., Lynch, J., and Brecher, P. 2000. Nitric oxide increases p21(Waf1/Cip1) expression by a cGMP-dependent pathway that includes activation of extracellular signal-regulated kinase and p70(S6k). J. Biol. Chem. 275: 11389-11396.
15. Guarente, L. and Kenyon, C. 2000. Genetic pathways that regulate ageing in model organisms. Nature 408: 255-262.
16. Guevara-Aguirre, J., Rosenbloom, A.L., Vasconez, O., Martinez, V., Gargosky, S.E., Allen, L., and Rosenfeld, R.G. 1997. Two-year treatment of growth hormone (GH) receptor deficiency with recombinant insulin-like growth factor I in 22 children: Comparison of two dosage levels and to GH-treated GH deficiency. J. Clin. Endocrinol. Metab. 82: 629-633.
17. Holzenberger, M., Dupont, J., Ducos, B., Leneuve, P., Geloen, A., Even, P.C., Cervera, P., and Le Bouc, Y. 2003. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182-187.
18. Imai, S., Armstrong, C.M., Kaeberlein, M., and Guarente, L. 2000. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403: 795-800.
19. Jin, S., Martinek, S., Joo, W.S., Wortman, J.R., Mirkovic, N., Sali, A., Yandell, M.D., Pavletich, N.P., Young, M.W., and Levine, A.J. 2000. Identification and characterization of a p53 homologue in Drosophila melanogaster. Proc. Natl. Acad. Sci. 97: 7301-7306.
20. Lavigueur, A., Maltby, V., Mock, D., Rossant, J., Pawson, T., and Bernstein, A. 1989. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell. Biol. 9: 3982-3991.
21. Lin, S.J., Defossez, P.A., and Guarente, L. 2000. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126-2128.
22. Luo, J., Nikolaev, A.Y., Imai, S., Chen, D., Su, F., Shiloh, A., Guarente, L., and Gu, W. 2001. Negative control of p53 by Sir2α promotes cell survival under stress. Cell 107: 137-148.
23. Lupu, F., Terwilliger, J.D., Lee, K., Segre, G.V., and Efstratiadis, A. 2001. Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev. Biol. 229: 141-162.
24. Meloche, S., Seuwen, K., Pages, G., and Pouyssegur, J. 1992. Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: Correlation between late phase activation and mitogenicity. Mol. Endocrinol. 6: 845-854.
25. Miller, S.J., Lou, D.Y., Seldin, D.C., Lane, W.S., and Neel, B.G. 2002. Direct identification of PTEN phosphorylation sites. FEBS Lett. 528: 145-153.
26. Mowat, M., Cheng, A., Kimura, N., Bernstein, A., and Benchimol, S. 1985. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature 314: 633-636.
27. Ollmann, M., Young, L.M., Di Como, C.J., Karim, F., Belvin, M., Robertson, S., Whittaker, K., Demsky, M., Fisher, W.W., Buchman, A., et al. 2000. Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell 101: 91-101.
28. Parfitt, A.M., Drezner, M.K., Glorieux, F.H., Kanis, J.A., Malluche, H., Meunier, P.J., Ott, S.M., and Recker, R.R. 1987. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2: 595-610.
29. Roovers, K. and Assoian, R.K. 2000. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22: 818-826.
30. Rosenfeld, R.G., Rosenbloom, A.L., and Guevara-Aguirre, J. 1994. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr. Rev. 15: 369-390.
31. Rovinski, B. and Benchimol, S. 1988. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Oncogene 2: 445-452.
32. Rovinski, B., Munroe, D., Peacock, J., Mowat, M., Bernstein, A., and Benchimol, S. 1987. Deletion of 5′-coding sequences of the cellular p53 gene in mouse erythroleukemia: A novel mechanism of oncogene regulation. Mol. Cell. Biol. 7: 847-853.
33. Schuster, N., Gotz, C., Faust, M., Schneider, E., Prowald, A., Jungbluth, A., and Montenarh, M. 2001. Wild-type p53 inhibits protein kinase CK2 activity. J. Cell. Biochem. 81: 172-183.
34. Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S., and Mak, T.W. 2001. Regulation of PTEN transcription by p53. Mol. Cell 8: 317-325.
35. Tang, E.D., Nunez, G., Barr, F.G., and Guan, K.L. 1999. Negative regulation of the forkhead transcription factor FKHR by Akt. J. Biol. Chem. 274: 16741-16746.
36. Tatar, M., Kopelman, A., Epstein, D., Tu, M.P., Yin, C.M., and Garofalo, R.S. 2001. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292: 107-110.
37. Torres, J. and Pulido, R. 2001. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276: 993-998.
38. Trumpp, A., Refaeli, Y., Oskarsson, T., Gasser, S., Murphy, M., Martin, G.R., and Bishop, J.M. 2001. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature 414: 768-773.
39. Tyner, S.D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. 2002. p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45-53.
40. Vaziri, H., Dessain, S.K., Ng Eaton, E., Imai, S.I., Frye, R.A., Pandita, T.K., Guarente, L., and Weinberg, R.A. 2001. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107: 149-159.
41. Vazquez, F., Grossman, S.R., Takahashi, Y., Rokas, M.V., Nakamura, N., and Sellers, W.R. 2001. Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J. Biol. Chem. 276: 48627-48630.
42. Werner, H., Karnieli, E., Rauscher, F.J., and LeRoith, D. 1996. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. 93: 8318-8323.
43. Woods, D., Parry, D., Cherwinski, H., Bosch, E., Lees, E., and McMahon, M. 1997. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol. Cell. Biol. 17: 5598-5611.
44. Xiao, Y.Q., Malcolm, K., Worthen, G.S., Gardai, S., Schiemann, W.P., Fadok, V.A., Bratton, D.L., and Henson, P.M. 2002. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-β. J. Biol. Chem. 277: 14884-14893.
45. Yin, Y., Stephen, C.W., Luciani, M.G., and Fahraeus, R. 2002. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products. Nat. Cell Biol. 4: 462-467.
46. Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W.H., Tom, E., Mack, D.H., and Levine, A.J. 2000. The transcriptional program following p53 activation. Cold Spring Harb. Symp. Quant. Biol. 65: 475-482.